These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21483629)

  • 21. Phenylpropanoid glycosides from plant cell cultures induce heme oxygenase 1 gene expression in a human keratinocyte cell line by affecting the balance of NRF2 and BACH1 transcription factors.
    Sgarbossa A; Dal Bosco M; Pressi G; Cuzzocrea S; Dal Toso R; Menegazzi M
    Chem Biol Interact; 2012 Aug; 199(2):87-95. PubMed ID: 22735309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy.
    Kumthip K; Pantip C; Chusri P; Thongsawat S; O'Brien A; Nelson KE; Maneekarn N
    J Viral Hepat; 2011 Apr; 18(4):e117-25. PubMed ID: 20955493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.
    Boson B; Denolly S; Turlure F; Chamot C; Dreux M; Cosset FL
    Gastroenterology; 2017 Mar; 152(4):895-907.e14. PubMed ID: 27932311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein.
    Tellinghuisen TL; Foss KL; Treadaway J
    PLoS Pathog; 2008 Mar; 4(3):e1000032. PubMed ID: 18369478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly.
    Appel N; Zayas M; Miller S; Krijnse-Locker J; Schaller T; Friebe P; Kallis S; Engel U; Bartenschlager R
    PLoS Pathog; 2008 Mar; 4(3):e1000035. PubMed ID: 18369481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C Virus Nonstructural 5A Protein (HCV-NS5A) Inhibits Hepatocyte Apoptosis through the NF-κb/miR-503/bcl-2 Pathway.
    Xie Z; Xiao Z; Wang F
    Mol Cells; 2017 Mar; 40(3):202-210. PubMed ID: 28343379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells.
    Tseng CK; Hsu SP; Lin CK; Wu YH; Lee JC; Young KC
    Antiviral Res; 2017 Oct; 146():191-200. PubMed ID: 28935193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.
    Mathiesen CK; Prentoe J; Meredith LW; Jensen TB; Krarup H; McKeating JA; Gottwein JM; Bukh J
    J Virol; 2015 Aug; 89(15):7758-75. PubMed ID: 25995244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between Nonstructural Proteins NS4B and NS5A Is Essential for Proper NS5A Localization and Hepatitis C Virus RNA Replication.
    Biswas A; Treadaway J; Tellinghuisen TL
    J Virol; 2016 Aug; 90(16):7205-7218. PubMed ID: 27252526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 controls hepatitis C virus non-structural protein 5A-mediated downregulation of GADD45α expression via the NF-κB and PI3K-Akt pathways.
    Cheng D; Zhao L; Zhang L; Jiang Y; Tian Y; Xiao X; Gong G
    J Gen Virol; 2013 Feb; 94(Pt 2):326-335. PubMed ID: 23114628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells.
    Ivanov AV; Smirnova OA; Ivanova ON; Masalova OV; Kochetkov SN; Isaguliants MG
    PLoS One; 2011; 6(9):e24957. PubMed ID: 21931870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes.
    Ghosh S; Ahrens WA; Phatak SU; Hwang S; Schrum LW; Bonkovsky HL
    J Viral Hepat; 2011 Oct; 18(10):e568-77. PubMed ID: 21914078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.
    Pham LV; Ramirez S; Carlsen THR; Li YP; Gottwein JM; Bukh J
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B.
    Esser-Nobis K; Romero-Brey I; Ganten TM; Gouttenoire J; Harak C; Klein R; Schemmer P; Binder M; Schnitzler P; Moradpour D; Bartenschlager R; Polyak SJ; Stremmel W; Penin F; Eisenbach C; Lohmann V
    Hepatology; 2013 Mar; 57(3):953-63. PubMed ID: 23322644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy.
    El-Shamy A; Shoji I; Saito T; Watanabe H; Ide YH; Deng L; Kawata S; Hotta H
    Microbiol Immunol; 2011 Jun; 55(6):418-26. PubMed ID: 21371092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations.
    Scheel TK; Gottwein JM; Carlsen TH; Li YP; Jensen TB; Spengler U; Weis N; Bukh J
    J Virol; 2011 Mar; 85(6):2891-906. PubMed ID: 21177811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus proteins inhibit C3 complement production.
    Mazumdar B; Kim H; Meyer K; Bose SK; Di Bisceglie AM; Ray RB; Ray R
    J Virol; 2012 Feb; 86(4):2221-8. PubMed ID: 22171262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations.
    Pietschmann T; Zayas M; Meuleman P; Long G; Appel N; Koutsoudakis G; Kallis S; Leroux-Roels G; Lohmann V; Bartenschlager R
    PLoS Pathog; 2009 Jun; 5(6):e1000475. PubMed ID: 19521536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.
    Berger C; Romero-Brey I; Radujkovic D; Terreux R; Zayas M; Paul D; Harak C; Hoppe S; Gao M; Penin F; Lohmann V; Bartenschlager R
    Gastroenterology; 2014 Nov; 147(5):1094-105.e25. PubMed ID: 25046163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seed sequence-matched controls reveal limitations of small interfering RNA knockdown in functional and structural studies of hepatitis C virus NS5A-MOBKL1B interaction.
    Chung HY; Gu M; Buehler E; MacDonald MR; Rice CM
    J Virol; 2014 Oct; 88(19):11022-33. PubMed ID: 25031347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.